Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

NCT03275103

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital - Arizona Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

NCT04116437

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +29 more
Locations
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
  • Christiana Care Newark, Delaware, United States
  • Scri Florida Cancer Specialists South Fort Myers, Florida, United States
  • St Century Oncology Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details

Related conditions